Luciana Borio

Luciana Borio

Director/Board Member bei EAGLE PHARMACEUTICALS, INC.

Vermögen: 390 449 $ am 31.03.2024

53 Jahre
Finance
Health Technology
Consumer Services

Profil

Luciana Borio, M.D., is a Venture Partner at ARCH Venture Partners.
In this capacity, she advises on and helps develop new investment opportunities related to biologics manufacturing, clinical trials, novel therapies and areas with large unmet clinical needs.
Dr. Borio is a specialist in biodefense, emerging infectious diseases, medical product development, and complex public health emergencies.
Prior to joining ARCH, she was a senior vice president at In-Q-Tel, an independent, non-profit, strategic investment firm that works to deliver innovative technology solutions to support the missions of the U.S.
Intelligence Community.
Past positions include serving as a member of President Biden’s transition COVID-19 Advisory Board and Director for Medical and Biodefense Preparedness at the National Security Council (2017-2019), where she coordinated the response to the Ebola epidemic in West Africa, efforts to combat antimicrobial resistance, and the development of an Executive Order to modernize America’s influenza vaccines.
Prior to that, she was the Acting Chief Scientist of the U.S.
Food and Drug Administration (2015-2017) and the Assistant Commissioner for Counterterrorism Policy of the FDA (2010-2017).
Dr. Borio is an adjunct Assistant Professor of Medicine at Johns Hopkins University (2003-present), where she continues to practice medicine part-time.
She is also a senior fellow for global health at the Council on Foreign Relations.
Dr. Borio obtained her M.D.
from George Washington University, completed a residency in internal medicine at New York-Presbyterian/Weill Cornell Medical Center, and a combined fellowship in infectious diseases at Johns Hopkins and critical care at the National Institutes of Health.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
26.03.2024 2 278 ( 0,00% ) 390 449 $ 31.03.2024
31.03.2023 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Luciana Borio

UnternehmenPositionBeginn
EAGLE PHARMACEUTICALS, INC. Director/Board Member 28.04.2021
INSULET CORPORATION Director/Board Member 18.10.2021
Director/Board Member 25.10.2021
Private Equity Investor 01.12.2021
Director/Board Member -
Alle aktiven Positionen von Luciana Borio

Ehemalige bekannte Positionen von Luciana Borio

UnternehmenPositionEnde
Corporate Officer/Principal 01.01.2020
National Security Council Corporate Officer/Principal 01.01.2019
Corporate Officer/Principal 01.01.2017
Corporate Officer/Principal 01.10.2008
Sehen Sie sich die Erfahrung von Luciana Borio im Detail an

Ausbildung von Luciana Borio

George Washington University Undergraduate Degree
George Washington University School of Medicine & Health Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Luciana Borio im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

11

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
EAGLE PHARMACEUTICALS, INC.

Health Technology

INSULET CORPORATION

Health Technology

Private Unternehmen7

Finance

Commercial Services

Government

Finance

National Security Council

Technology Services

Commercial Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Luciana Borio